1NO9 | date | ![]() |
|||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
authors | |||||||||||||||
compound | source | ||||||||||||||
symmetry |
| ||||||||||||||
crystal cell |
| ||||||||||||||
method | X-Ray Diffraction | resolution | |||||||||||||
ligand | 4ND, NAG, TYS | enzyme |
| ||||||||||||
related structures | by homologous chain: 1K21, 1TA6, 1XMN | ||||||||||||||
Gene Ontology ![]() |
| ||||||||||||||
Primary reference | Design of weakly basic thrombin inhibitors incorporating novel P1 binding functions: molecular and X-ray crystallographic studies., De Simone G, Menchise V, Omaggio S, Pedone C, Scozzafava A, Supuran CT, Biochemistry 2003 Aug 5;42(30):9013-21. PMID:12885234 |
Data retrieval |
![]() |
View 1NO9 in 3D |
![]() |
Structure-derived information |
Sequence-derived information |
OCA© by Jaime Prilusky, 1996-2014,2022,2024 Bioinformatics Unit Weizmann Institute of Science |